뉴스벤징가
Teva's Innovative Drug Portfolio Fuels Growth as Company Raises Outlook, Transitions to Direct NYSE Listing
· 발표
기사 요약
Teva revenue tops estimates despite an earnings miss. The company raises 2026 sales guidance and highlights strong brand growth.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…